×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!

PAREXEL's Chuck Stevens discusses how orphan products has changed payer perceptions at DIA 2013

June 13, 2013
PAREXEL's Chuck Stevens, will speak at DIA 2013 in Boston and examine how increased development of orphan products has changed how payer regulators view rare diseases. His presentation will cover how rare disorders can now have several products FDA indicated for use; which requires developers demonstrate the value of these rare disease products in ways that were previously not required. Mr. Stevens will be joined by Paul Kim, a partner at the law firm of Foley Hoag and by Jim Long, co-founder and principal at BioSolutia.
Previous Video
A Focus on Service
A Focus on Service

In this video, PAREXEL International Chairman of the Board and CEO Josef von Rickenbach takes a look at the...

Next Video
Joshua Schultz comments on Strategic Partnership 2013 Report
Joshua Schultz comments on Strategic Partnership 2013 Report

Joshua Schultz, VP of Strategic Partnerships at PAREXEL comments on a ground breaking research report on th...